Caitong International Asset Management Co., LTD Amicus Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 351 shares of FOLD stock, worth $3,457. This represents 0.0% of its overall portfolio holdings.
Number of Shares
351
Previous 351
-0.0%
Holding current value
$3,457
Previous $3.31 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
311Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$288 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$280 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$240 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$239 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$228 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.76B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...